Charting Biologically Relevant Spirocyclic Compound Space

被引:123
作者
Mueller, Gerhard [1 ]
Berkenbosch, Tim [1 ]
Benningshof, Jorg C. J. [1 ]
Stumpfe, Dagmar [2 ]
Bajorath, Juergen [2 ]
机构
[1] Mercachem, Kerkenbos 1013, NL-6546 BB Nijmegen, Netherlands
[2] Rhein Friedrich Wilhelms Univ, LIMES Program Unit Chem Biol & Med Chem, Dept Life Sci Informat, B IT, Dahlmannstr 2, D-53113 Bonn, Germany
关键词
compound distribution; computational analysis; scaffold synthesis; spiro compounds; structural biology; ORIENTED SYNTHESIS; NATURAL-PRODUCTS; NK1; ANTAGONISTS; DRUG DISCOVERY; SCAFFOLDS; NORFLUOROCURARINE; IDENTIFICATION; INHIBITORS; DIVERSITY; POTENT;
D O I
10.1002/chem.201604714
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Spirocycles frequently occur in natural products and experience increasing interest in drug discovery, given their richness in sp(3) centers and distinct three-dimensionality. We have systematically explored chemical space populated with currently available bioactive spirocycles. Compounds containing spiro systems were classified and their scaffolds and spirocyclic ring combinations analyzed. Nearly 47 000 compounds were identified that contained spirocycles in different structural contexts and were active against roughly 200 targets, among which several pharmaceutically relevant members of the G protein-coupled receptor (GPCR) family were identified. Spirocycles and corresponding compounds displayed notable scaffold diversity but contained only limited numbers of combinations of differently sized rings. These observations indicate that there should be significant potential to further expand spirocyclic chemical space for drug discovery, exploiting the privileged substructure concept. Inspired by those findings, we embarked on the design and chemical synthesis of three distinct novel spirocyclic scaffolds that qualify for downstream library synthesis, thus exploring principally new chemical space with high potential for pharmaceutical research.
引用
收藏
页码:703 / 710
页数:8
相关论文
共 32 条
[1]  
[Anonymous], 2004, ANGEW CHEM
[2]   The properties of known drugs .1. Molecular frameworks [J].
Bemis, GW ;
Murcko, MA .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (15) :2887-2893
[3]   KNIME:: The Konstanz Information Miner [J].
Berthold, Michael R. ;
Cebron, Nicolas ;
Dill, Fabian ;
Gabriel, Thomas R. ;
Koetter, Tobias ;
Meinl, Thorsten ;
Ohl, Peter ;
Sieb, Christoph ;
Thiel, Kilian ;
Wiswedel, Bernd .
DATA ANALYSIS, MACHINE LEARNING AND APPLICATIONS, 2008, :319-326
[4]   A planning strategy for diversity-oriented synthesis [J].
Burke, MD ;
Schreiber, SL .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2004, 43 (01) :46-58
[5]   A Longitudinal Study of Alkaloid Synthesis Reveals Functional Group Interconversions as Bad Actors [J].
Crossley, Steven W. M. ;
Shenvi, Ryan A. .
CHEMICAL REVIEWS, 2015, 115 (17) :9465-9531
[6]   Stereoselective Synthesis of 1-Methyl-3′,4′,5′,6′-tetrahydrospiro[indoline-3,2′-pyran]-2-one Derivatives via Prins Cyclization [J].
Damera, Krishna ;
Yu, Bingchen ;
Wang, Binghe .
JOURNAL OF ORGANIC CHEMISTRY, 2015, 80 (11) :5457-5463
[7]   ChEMBL: a large-scale bioactivity database for drug discovery [J].
Gaulton, Anna ;
Bellis, Louisa J. ;
Bento, A. Patricia ;
Chambers, Jon ;
Davies, Mark ;
Hersey, Anne ;
Light, Yvonne ;
McGlinchey, Shaun ;
Michalovich, David ;
Al-Lazikani, Bissan ;
Overington, John P. .
NUCLEIC ACIDS RESEARCH, 2012, 40 (D1) :D1100-D1107
[8]   Macrocyclic Drugs and Clinical Candidates: What Can Medicinal Chemists Learn from Their Properties? [J].
Giordanetto, Fabrizio ;
Kihlberg, Jan .
JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (02) :278-295
[9]   Scaffold diversity of natural products: inspiration for combinatorial library design [J].
Grabowski, Kristina ;
Baringhaus, Karl-Heinz ;
Schneider, Gisbert .
NATURAL PRODUCT REPORTS, 2008, 25 (05) :892-904
[10]   The re-emergence of natural products for drug discovery in the genomics era [J].
Harvey, Alan L. ;
Edrada-Ebel, RuAngelie ;
Quinn, Ronald J. .
NATURE REVIEWS DRUG DISCOVERY, 2015, 14 (02) :111-129